Exploring the Complement Interaction Network Using Surface Plasmon Resonance

  • Daniel Ricklin
  • John D. Lambris
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 598)


Surface Plasmon Resonance Isothermal Titration Calorimetry Sensor Chip Membrane Attack Complex Surface Plasmon Resonance Biosensor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abdul Ajees, A., Gunasekaran, K., Volanakis, J.E., Narayana, S.V., Kotwal, G.J. and Krishna Murthy, H.M. (2006) The structure of complement C3b provides insights into complement activation and regulation. Nature 444, 221-225.PubMedCrossRefGoogle Scholar
  2. Alitalo, A., Meri, T., Chen, T., Lankinen, H., Cheng, Z.Z., Jokiranta, T.S., Seppala, I.J., Lahdenne, P., Hefty, P.S., Akins, D.R. and Meri, S. (2004) Lysine-dependent multipoint binding of the Borrelia burgdorferi virulence factor outer surface protein E to the C terminus of factor H. J Immunol 172, 6195-6201.PubMedGoogle Scholar
  3. Alitalo, A., Meri, T., Comstedt, P., Jeffery, L., Tornberg, J., Strandin, T., Lankinen, H., Bergstrom, S., Cinco, M., Vuppala, S.R., Akins, D.R. and Meri, S. (2005) Expression of complement factor H binding immunoevasion proteins in Borrelia garinii isolated from patients with neuroborreliosis. Eur J Immunol 35, 3043-3053.PubMedCrossRefGoogle Scholar
  4. Asokan, R., Hua, J., Young, K.A., Gould, H.J., Hannan, J.P., Kraus, D.M., Szakonyi, G., Grundy, G.J., Chen, X.S., Crow, M.K. and Holers, V.M. (2006) Characterization of human complement receptor type 2 (CR2/CD21) as a receptor for IFN-alpha: a potential role in systemic lupus erythematosus. J Immunol 177, 383-394.PubMedGoogle Scholar
  5. Basta, M., Van Goor, F., Luccioli, S., Billings, E.M., Vortmeyer, A.O., Baranyi, L., Szebeni, J., Alving, C.R., Carroll, M.C., Berkower, I., Stojilkovic, S.S. and Metcalfe, D.D. (2003) F(ab)’2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins. Nat Med 9, 431-438.PubMedCrossRefGoogle Scholar
  6. Bergwerff, A.A. and van Knapen, F. (2006) Surface plasmon resonance biosensors for detection of pathogenic microorganisms: strategies to secure food and environmental safety. J AOAC Int 89, 826-831.PubMedGoogle Scholar
  7. Bernet, J., Mullick, J., Panse, Y., Parab, P.B. and Sahu, A. (2004) Kinetic analysis of the interactions between vaccinia virus complement control protein and human complement proteins C3b and C4b. J Virol 78, 9446-9457.PubMedCrossRefGoogle Scholar
  8. Blanquet-Grossard, F., Thielens, N.M., Vendrely, C., Jamin, M. and Arlaud, G.J. (2005) Complement protein C1q recognizes a conformationally modified form of the prion protein. Biochemistry 44, 4349-4356.PubMedCrossRefGoogle Scholar
  9. Buijs, J. and Franklin, G.C. (2005) SPR-MS in functional proteomics. Brief Funct Genomic Proteomic 4, 39-47.PubMedCrossRefGoogle Scholar
  10. Cannon, M.J., Papalia, G.A., Navratilova, I., Fisher, R.J., Roberts, L.R., Worthy, K.M., Stephen, A.G., Marchesini, G.R., Collins, E.J., Casper, D., Qiu, H., Satpaev, D., Liparoto, S.F., Rice, D.A., Gorshkova, II, Darling, R.J., Bennett, D.B., Sekar, M., Hommema, E., Liang, A.M., Day, E.S., Inman, J., Karlicek, S.M., Ullrich, S.J., Hodges, D., Chu, T., Sullivan, E., Simpson, J., Rafique, A., Luginbuhl, B., Westin, S.N., Bynum, M., Cachia, P., Li, Y.J., Kao, D., Neurauter, A., Wong, M., Swanson, M. and Myszka, D.G. (2004) Comparative analyses of a small molecule/enzyme interaction by multiple users of Biacore technology. Anal Biochem 330, 98-113.PubMedCrossRefGoogle Scholar
  11. Catimel, B., Nerrie, M., Lee, F.T., Scott, A.M., Ritter, G., Welt, S., Old, L.J., Burgess, A.W. and Nice, E.C. (1997) Kinetic analysis of the interaction between the monoclonal antibody A33 and its colonic epithelial antigen by the use of an optical biosensor. A comparison of immobilisation strategies. J Chromatogr A 776, 15-30.PubMedCrossRefGoogle Scholar
  12. Cheng, Z.Z., Hellwage, J., Seeberger, H., Zipfel, P.F., Meri, S. and Jokiranta, T.S. (2006) Comparison of surface recognition and C3b binding properties of mouse and human complement factor H. Mol Immunol 43, 972-979.PubMedCrossRefGoogle Scholar
  13. Cooper, M.A. (2002) Optical biosensors in drug discovery. Nat Rev Drug Discov 1, 515-528.PubMedCrossRefGoogle Scholar
  14. Dave, S., Carmicle, S., Hammerschmidt, S., Pangburn, M.K. and McDaniel, L.S. (2004) Dual roles of PspC, a surface protein of Streptococcus pneumoniae, in binding human secretory IgA and factor H. J Immunol 173, 471-477.PubMedGoogle Scholar
  15. de Mol, N.J., Dekker, F.J., Broutin, I., Fischer, M.J. and Liskamp, R.M. (2005) Surface plasmon resonance thermodynamic and kinetic analysis as a strategic tool in drug design. Distinct ways for phosphopeptides to plug into Src- and Grb2 SH2 domains. J Med Chem 48, 753-763.PubMedCrossRefGoogle Scholar
  16. Del Conde, I., Cruz, M.A., Zhang, H., Lopez, J.A. and Afshar-Kharghan, V. (2005) Platelet activation leads to activation and propagation of the complement system. J Exp Med 201, 871-879.PubMedCrossRefGoogle Scholar
  17. Evenas, P., Garcia De Frutos, P., Linse, S. and Dahlback, B. (1999) Both G-type domains of protein S are required for the high-affinity interaction with C4b-binding protein. Eur J Biochem 266, 935-942.PubMedCrossRefGoogle Scholar
  18. Fagerstam, L.G., Frostell-Karlsson, A., Karlsson, R., Persson, B. and Ronnberg, I. (1992) Biospecific interaction analysis using surface plasmon resonance detection applied to kinetic, binding site and concentration analysis. J Chromatogr 597, 397-410.PubMedCrossRefGoogle Scholar
  19. Fujita, E., Farkas, I., Campbell, W., Baranyi, L., Okada, H. and Okada, N. (2004) Inactivation of C5a anaphylatoxin by a peptide that is complementary to a region of C5a. J Immunol 172, 6382-6387.PubMedGoogle Scholar
  20. Fung, M., Lu, M., Fure, H., Sun, W., Sun, C., Shi, N.Y., Dou, Y., Su, J., Swanson, X. and Mollnes, T.E. (2003) Pre-neutralization of C5a-mediated effects by the monoclonal antibody 137-26 reacting with the C5a moiety of native C5 without preventing C5 cleavage. Clin Exp Immunol 133, 160-169.PubMedCrossRefGoogle Scholar
  21. Gambari, R. and Feriotto, G. (2006) Surface plasmon resonance for detection of genetically modified organisms in the food supply. J AOAC Int 89, 893-897.PubMedGoogle Scholar
  22. Giri, T.K., Linse, S., Garcia de Frutos, P., Yamazaki, T., Villoutreix, B.O. and Dahlback, B. (2002) Structural requirements of anticoagulant protein S for its binding to the complement regulator C4b-binding protein. J Biol Chem 277, 15099-15106.PubMedCrossRefGoogle Scholar
  23. Goodfellow, I.G., Evans, D.J., Blom, A.M., Kerrigan, D., Miners, J.S., Morgan, B.P. and Spiller, O.B. (2005) Inhibition of coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors. J Virol 79, 12016-12024.Google Scholar
  24. Harris, C.L., Abbott, R.J., Smith, R.A., Morgan, B.P. and Lea, S.M. (2005) Molecular dissection of interactions between components of the alternative pathway of complement and decay accelerating factor (CD55). J Biol Chem 280, 2569-2578.PubMedCrossRefGoogle Scholar
  25. He, X., Shen, L., Malmborg, A.C., Smith, K.J., Dahlback, B. and Linse, S. (1997) Binding site for C4b-binding protein in vitamin K-dependent protein S fully contained in carboxy-terminal laminin-G-type repeats. A study using recombinant factor IX-protein S chimeras and surface plasmon resonance. Biochemistry 36, 3745-3754.PubMedCrossRefGoogle Scholar
  26. Hellwage, J., Jokiranta, T.S., Friese, M.A., Wolk, T.U., Kampen, E., Zipfel, P.F. and Meri, S. (2002) Complement C3b/C3d and cell surface polyanions are recognized by overlapping binding sites on the most carboxyl-terminal domain of complement factor H. J Immunol 169, 6935-6944.PubMedGoogle Scholar
  27. Hellwage, J., Meri, T., Heikkila, T., Alitalo, A., Panelius, J., Lahdenne, P., Seppala, I.J. and Meri, S. (2001) The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi. J Biol Chem 276, 8427-8435.PubMedCrossRefGoogle Scholar
  28. Hourcade, D.E. (2006) The role of properdin in the assembly of the alternative pathway C3 convertases of complement. J Biol Chem 281, 2128-2132.PubMedCrossRefGoogle Scholar
  29. Ioannou, Y. and Isenberg, D.A. (2000) Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy. Arthritis Rheum 43, 1431-1442.PubMedCrossRefGoogle Scholar
  30. James, J.A., Kaufman, K.M., Farris, A.D., Taylor-Albert, E., Lehman, T.J. and Harley, J.B. (1997) An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest 100, 3019-3026.PubMedCrossRefGoogle Scholar
  31. Janssen, B.J., Christodoulidou, A., McCarthy, A., Lambris, J.D. and Gros, P. (2006) Structure of C3b reveals conformational changes that underlie complement activity. Nature 444, 213-216.PubMedCrossRefGoogle Scholar
  32. Janssen, B.J., Huizinga, E.G., Raaijmakers, H.C., Roos, A., Daha, M.R., Nilsson-Ekdahl, K., Nilsson, B. and Gros, P. (2005) Structures of complement component C3 provide insights into the function and evolution of immunity. Nature 437, 505-511.PubMedCrossRefGoogle Scholar
  33. Janulczyk, R., Iannelli, F., Sjoholm, A.G., Pozzi, G. and Bjorck, L. (2000) Hic, a novel surface protein of Streptococcus pneumoniae that interferes with complement function. J Biol Chem 275, 37257-37263.PubMedCrossRefGoogle Scholar
  34. Jarva, H., Hellwage, J., Jokiranta, T.S., Lehtinen, M.J., Zipfel, P.F. and Meri, S. (2004) The group B streptococcal beta and pneumococcal Hic proteins are structurally related immune evasion molecules that bind the complement inhibitor factor H in an analogous fashion. J Immunol 172, 3111-3118.PubMedGoogle Scholar
  35. Jarva, H., Janulczyk, R., Hellwage, J., Zipfel, P.F., Bjorck, L. and Meri, S. (2002) Streptococcus pneumoniae evades complement attack and opsonophagocytosis by expressing the pspC locus-encoded Hic protein that binds to short consensus repeats 8-11 of factor H. J Immunol 168, 1886-1894.PubMedGoogle Scholar
  36. Johnsson, B., Lofas, S. and Lindquist, G. (1991) Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors. Anal Biochem 198, 268-277.PubMedCrossRefGoogle Scholar
  37. Jokiranta, T.S., Cheng, Z.Z., Seeberger, H., Jozsi, M., Heinen, S., Noris, M., Remuzzi, G., Ormsby, R., Gordon, D.L., Meri, S., Hellwage, J. and Zipfel, P.F. (2005) Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site. Am J Pathol 167, 1173-1181.PubMedGoogle Scholar
  38. Jokiranta, T.S., Hellwage, J., Koistinen, V., Zipfel, P.F. and Meri, S. (2000) Each of the three binding sites on complement factor H interacts with a distinct site on C3b. J Biol Chem 275, 27657-27662.PubMedGoogle Scholar
  39. Jokiranta, T.S., Westin, J., Nilsson, U.R., Nilsson, B., Hellwage, J., Lofas, S., Gordon, D.L., Ekdahl, K.N. and Meri, S. (2001) Complement C3b interactions studied with surface plasmon resonance technique. Int Immunopharmacol 1, 495-506.PubMedCrossRefGoogle Scholar
  40. Jonsson, U., Fagerstam, L., Ivarsson, B., Johnsson, B., Karlsson, R., Lundh, K., Lofas, S., Persson, B., Roos, H., Ronnberg, I., Sjolander, S., Stenberg, E., Stahlberg, R., Urbaniczky, C., Ostlin, H. and Malmqvist, M. (1991) Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. Biotechniques 11, 620-627.PubMedGoogle Scholar
  41. Karlsson, R., Kullman-Magnusson, M., Hamalainen, M.D., Remaeus, A., Andersson, K., Borg, P., Gyzander, E. and Deinum, J. (2000) Biosensor analysis of drug-target interactions: direct and competitive binding assays for investigation of interactions between thrombin and thrombin inhibitors. Anal Biochem 278, 1-13.PubMedCrossRefGoogle Scholar
  42. Katsamba, P.S., Navratilova, I., Calderon-Cacia, M., Fan, L., Thornton, K., Zhu, M., Bos, T.V., Forte, C., Friend, D., Laird-Offringa, I., Tavares, G., Whatley, J., Shi, E., Widom, A., Lindquist, K.C., Klakamp, S., Drake, A., Bohmann, D., Roell, M., Rose, L., Dorocke, J., Roth, B., Luginbuhl, B. and Myszka, D.G. (2006) Kinetic analysis of a high-affinity antibody/antigen interaction performed by multiple Biacore users. Anal Biochem 352, 208-221.PubMedCrossRefGoogle Scholar
  43. Keusgen, M. (2002) Biosensors: new approaches in drug discovery. Naturwissenschaften 89, 433-444.PubMedCrossRefGoogle Scholar
  44. Kikuchi, Y., Uno, S., Nanami, M., Yoshimura, Y., Iida, S., Fukushima, N. and Tsuchiya, M. (2005) Determination of concentration and binding affinity of antibody fragments by use of surface plasmon resonance. J Biosci Bioeng 100, 311-317.PubMedCrossRefGoogle Scholar
  45. Kindermann, M., George, N., Johnsson, N. and Johnsson, K. (2003) Covalent and selective immobilization of fusion proteins. J Am Chem Soc 125, 7810-7811.PubMedCrossRefGoogle Scholar
  46. Kirkitadze, M.D. and Barlow, P.N. (2001) Structure and flexibility of the multiple domain proteins that regulate complement activation. Immunol Rev 180, 146-161.PubMedCrossRefGoogle Scholar
  47. Lambris, J.D., Sahu, A. and Wetsel, R. (1998). The chemistry and biology of C3, C4, and C5. In: J.E. Volanikis and M. Frank (Eds.), The human complement system in health and disease. Marcel Dekker Inc., New York, pp. 83-118.Google Scholar
  48. Lea, S.M., Powell, R.M., McKee, T., Evans, D.J., Brown, D., Stuart, D.I. and van der Merwe, P.A. (1998) Determination of the affinity and kinetic constants for the interaction between the human virus echovirus 11 and its cellular receptor, CD55. J Biol Chem 273, 30443-30447.PubMedCrossRefGoogle Scholar
  49. Lindahl, G., Sjobring, U. and Johnsson, E. (2000) Human complement regulators: a major target for pathogenic microorganisms. Curr Opin Immunol 12, 44-51.PubMedCrossRefGoogle Scholar
  50. Malmqvist, M. (1993) Biospecific interaction analysis using biosensor technology. Nature 361, 186-187.PubMedCrossRefGoogle Scholar
  51. Markgren, P.O., Schaal, W., Hamalainen, M., Karlen, A., Hallberg, A., Samuelsson, B. and Danielson, U.H. (2002) Relationships between structure and interaction kinetics for HIV-1 protease inhibitors. J Med Chem 45, 5430-5439.PubMedCrossRefGoogle Scholar
  52. Markiewski, M.M., Nilsson, B., Nilsson Ekdahl, K., Mollnes, T.E. and Lambris, J.D. (2007) Complement and Coagulation: Strangers or Partners in Crime? Immunology.Google Scholar
  53. Mastellos, D., Morikis, D., Isaacs, S.N., Holland, M.C., Strey, C.W. and Lambris, J.D. (2003) Complement: structure, functions, evolution, and viral molecular mimicry. Immunol Res 27, 367-386.PubMedCrossRefGoogle Scholar
  54. Morton, T.A., Myszka, D.G. and Chaiken, I.M. (1995) Interpreting complex binding kinetics from optical biosensors: a comparison of analysis by linearization, the integrated rate equation, and numerical integration. Anal Biochem 227, 176-185.PubMedCrossRefGoogle Scholar
  55. Munoz, E.M., Yu, H., Hallock, J., Edens, R.E. and Linhardt, R.J. (2005) Poly(ethylene glycol)-based biosensor chip to study heparin-protein interactions. Anal Biochem 343, 176-178.PubMedCrossRefGoogle Scholar
  56. Myszka, D.G. (2004) Analysis of small-molecule interactions using Biacore S51 technology. Anal Biochem 329, 316-323.PubMedCrossRefGoogle Scholar
  57. Myszka, D.G. and Rich, R.L. (2000) Implementing surface plasmon resonance biosensors in drug discovery. Pharm. Sci. Technol. Today 3, 310-317.PubMedCrossRefGoogle Scholar
  58. Myszka, D.G. and Rich, R.L. (2003) SPR’s Impact on Drug Discovery: Resolution, Throughput, and Versatility. Drug Discovery World 5, 1-5.Google Scholar
  59. Nagar, B., Jones, R.G., Diefenbach, R.J., Isenman, D.E. and Rini, J.M. (1998) X-ray crystal structure of C3d: a C3 fragment and ligand for complement receptor 2. Science 280, 1277-1281.PubMedCrossRefGoogle Scholar
  60. Nagata, K. and Handa, H. (2000). Real-Time Analysis of Biomolecular Interactions: Applications of BIACORE. Springer, TokioGoogle Scholar
  61. Nedelkov, D. and Nelson, R.W. (2003) Surface plasmon resonance mass spectrometry: recent progress and outlooks. Trends Biotechnol 21, 301-305.PubMedCrossRefGoogle Scholar
  62. Nemerow, G.R., Mold, C., Schwend, V.K., Tollefson, V. and Cooper, N.R. (1987) Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d. J Virol 61, 1416-1420.PubMedGoogle Scholar
  63. Nilsson, B., Larsson, R., Hong, J., Elgue, G., Ekdahl, K.N., Sahu, A. and Lambris, J.D. (1998) Compstatin inhibits complement and cellular activation in whole blood in two models of extracorporeal circulation. Blood 92, 1661-1667.PubMedGoogle Scholar
  64. Pandiripally, V., Wei, L., Skerka, C., Zipfel, P.F. and Cue, D. (2003) Recruitment of complement factor H-like protein 1 promotes intracellular invasion by group A streptococci. Infect Immun 71, 7119-7128.PubMedCrossRefGoogle Scholar
  65. Pangburn, M.K. (2000) Host recognition and target differentiation by factor H, a regulator of the alternative pathway of complement. Immunopharmacology 49, 149-157.PubMedCrossRefGoogle Scholar
  66. Papalia, G.A., Leavitt, S., Bynum, M.A., Katsamba, P.S., Wilton, R., Qiu, H., Steukers, M., Wang, S., Bindu, L., Phogat, S., Giannetti, A.M., Ryan, T.E., Pudlak, V.A., Matusiewicz, K., Michelson, K.M., Nowakowski, A., Pham-Baginski, A., Brooks, J., Tieman, B.C., Bruce, B.D., Vaughn, M., Baksh, M., Cho, Y.H., Wit, M.D., Smets, A., Vandersmissen, J., Michiels, L. and Myszka, D.G. (2006) Comparative analysis of 10 small molecules binding to carbonic anhydrase II by different investigators using Biacore technology. Anal Biochem 359, 94-105.PubMedCrossRefGoogle Scholar
  67. Peluso, P., Wilson, D.S., Do, D., Tran, H., Venkatasubbaiah, M., Quincy, D., Heidecker, B., Poindexter, K., Tolani, N., Phelan, M., Witte, K., Jung, L.S., Wagner, P. and Nock, S. (2003) Optimizing antibody immobilization strategies for the construction of protein microarrays. Anal Biochem 312, 113-124.PubMedCrossRefGoogle Scholar
  68. Pettigrew, D., Anderson, K.L., Billington, J., Cota, E., Simpson, P., Urvil, P., Rabuzin, F., Roversi, P., Nowicki, B., du Merle, L., Le Bouguenec, C., Matthews, S. and Lea, S.M. (2004) High resolution studies of the Afa/Dr adhesin DraE and its interaction with chloramphenicol. J Biol Chem 279, 46851-46857.PubMedCrossRefGoogle Scholar
  69. Pettigrew, D.M., Williams, D.T., Kerrigan, D., Evans, D.J., Lea, S.M. and Bhella, D. (2006) Structural and functional insights into the interaction of echoviruses and decay-accelerating factor. J Biol Chem 281, 5169-5177.PubMedCrossRefGoogle Scholar
  70. Ponnuraj, K., Xu, Y., Macon, K., Moore, D., Volanakis, J.E. and Narayana, S.V. (2004) Structural analysis of engineered Bb fragment of complement factor B: insights into the activation mechanism of the alternative pathway C3-convertase. Mol Cell 14, 17-28.PubMedCrossRefGoogle Scholar
  71. Rasooly, A. and Herold, K.E. (2006) Biosensors for the analysis of food- and waterborne pathogens and their toxins. J AOAC Int 89, 873-883.PubMedGoogle Scholar
  72. Rautemaa, R. and Meri, S. (1999) Complement-resistance mechanisms of bacteria. Microbes Infect 1, 785-794.PubMedCrossRefGoogle Scholar
  73. Rich, R.L. and Myszka, D.G. (2000) Survey of the 1999 surface plasmon resonance biosensor literature. J Mol Recognit 13, 388-407.PubMedCrossRefGoogle Scholar
  74. Rich, R.L. and Myszka, D.G. (2001) Survey of the year 2000 commercial optical biosensor literature. J Mol Recognit 14, 273-294.PubMedCrossRefGoogle Scholar
  75. Rich, R.L. and Myszka, D.G. (2002) Survey of the year 2001 commercial optical biosensor literature. J Mol Recognit 15, 352-376.PubMedCrossRefGoogle Scholar
  76. Rich, R.L. and Myszka, D.G. (2003) A survey of the year 2002 commercial optical biosensor literature. J Mol Recognit 16, 351-382.PubMedCrossRefGoogle Scholar
  77. Rich, R.L. and Myszka, D.G. (2005a) Survey of the year 2003 commercial optical biosensor literature. J Mol Recognit 18, 1-39.CrossRefGoogle Scholar
  78. Rich, R.L. and Myszka, D.G. (2005b) Survey of the year 2004 commercial optical biosensor literature. J Mol Recognit 18, 431-478.CrossRefGoogle Scholar
  79. Rich, R.L. and Myszka, D.G. (2006) Survey of the year 2005 commercial optical biosensor literature. J Mol Recognit 19, 478-534.PubMedCrossRefGoogle Scholar
  80. Roden, L.D. and Myszka, D.G. (1996) Global analysis of a macromolecular interaction measured on BIAcore. Biochem Biophys Res Commun 225, 1073-1077.PubMedCrossRefGoogle Scholar
  81. Sahu, A., Kay, B.K. and Lambris, J.D. (1996) Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library. J Immunol 157, 884-891.PubMedGoogle Scholar
  82. Sahu, A., Morikis, D. and Lambris, J.D. (2003) Compstatin, a peptide inhibitor of complement, exhibits species-specific binding to complement component C3. Mol Immunol 39, 557-566.PubMedCrossRefGoogle Scholar
  83. Sahu, A., Soulika, A.M., Morikis, D., Spruce, L., Moore, W.T. and Lambris, J.D. (2000) Binding kinetics, structure-activity relationship, and biotransformation of the complement inhibitor compstatin. J Immunol 165, 2491-2499.PubMedGoogle Scholar
  84. Sarrias, M.R., Franchini, S., Canziani, G., Argyropoulos, E., Moore, W.T., Sahu, A. and Lambris, J.D. (2001) Kinetic analysis of the interactions of complement receptor 2 (CR2, CD21) with its ligands C3d, iC3b, and the EBV glycoprotein gp350/220. J Immunol 167, 1490-1499.PubMedGoogle Scholar
  85. Schwaeble, W.J. and Reid, K.B. (1999) Does properdin crosslink the cellular and the humoral immune response? Immunol Today 20, 17-21.PubMedCrossRefGoogle Scholar
  86. Sfyroera, G., Katragadda, M., Morikis, D., Isaacs, S.N. and Lambris, J.D. (2005) Electrostatic modeling predicts the activities of orthopoxvirus complement control proteins. J Immunol 174, 2143-2151.PubMedGoogle Scholar
  87. Smith, S.A., Sreenivasan, R., Krishnasamy, G., Judge, K.W., Murthy, K.H., Arjunwadkar, S.J., Pugh, D.R. and Kotwal, G.J. (2003) Mapping of regions within the vaccinia virus complement control protein involved in dose-dependent binding to key complement components and heparin using surface plasmon resonance. Biochim Biophys Acta 1650, 30-39.PubMedGoogle Scholar
  88. Soulika, A.M., Morikis, D., Sarrias, M.R., Roy, M., Spruce, L.A., Sahu, A. and Lambris, J.D. (2003) Studies of structure-activity relations of complement inhibitor compstatin. J Immunol 171, 1881-1890.PubMedGoogle Scholar
  89. Stenberg, E., Persson, B., Roos, H. and Urbaniczky, C. (1991) Quantitative determination of surface concentration of protein with surface plasmon resonance using radiolabeled proteins. J Colloid Interface Sci 143, 513-526.CrossRefGoogle Scholar
  90. Tanner, J., Weis, J., Fearon, D., Whang, Y. and Kieff, E. (1987) Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis. Cell 50, 203-213.PubMedCrossRefGoogle Scholar
  91. Thai, C.T. and Ogata, R.T. (2005) Recombinant C345C and factor I modules of complement components C5 and C7 inhibit C7 incorporation into the complement membrane attack complex. J Immunol 174, 6227-6232.PubMedGoogle Scholar
  92. Turbadar, T. (1959) Complete Absorption of Light by Thin Metal Films. Proceedings of the Physical Society of London 73, 40-44.CrossRefGoogle Scholar
  93. Vaziri-Sani, F., Hellwage, J., Zipfel, P.F., Sjoholm, A.G., Iancu, R. and Karpman, D. (2005) Factor H binds to washed human platelets. J Thromb Haemost 3, 154-162.PubMedCrossRefGoogle Scholar
  94. Verma, A., Hellwage, J., Artiushin, S., Zipfel, P.F., Kraiczy, P., Timoney, J.F. and Stevenson, B. (2006) LfhA, a novel factor H-binding protein of Leptospira interrogans. Infect Immun 74, 2659-2666.PubMedCrossRefGoogle Scholar
  95. Walport, M.J. (2001) Complement. First of two parts. N Engl J Med 344, 1058-1066.PubMedCrossRefGoogle Scholar
  96. Wear, M.A. and Walkinshaw, M.D. (2006) Thermodynamics of the cyclophilin-A/cyclosporin-A interaction: A direct comparison of parameters determined by surface plasmon resonance using Biacore T100 and isothermal titration calorimetry. Anal Biochem 359, 285-287.PubMedCrossRefGoogle Scholar
  97. Wiesmann, C., Katschke, K.J., Yin, J., Helmy, K.Y., Steffek, M., Fairbrother, W.J., McCallum, S.A., Embuscado, L., Deforge, L., Hass, P.E. and van Lookeren Campagne, M. (2006) Structure of C3b in complex with CRIg gives insights into regulation of complement activation. Nature 444, 217-220.PubMedCrossRefGoogle Scholar
  98. Winzor, D.J. (2003) Surface plasmon resonance as a probe of protein isomerization. Anal Biochem 318, 1-12.PubMedCrossRefGoogle Scholar
  99. Yu, H., Munoz, E.M., Edens, R.E. and Linhardt, R.J. (2005) Kinetic studies on the interactions of heparin and complement proteins using surface plasmon resonance. Biochim Biophys Acta 1726, 168-176.PubMedGoogle Scholar
  100. Yuk, J.S. and Ha, K.S. (2005) Proteomic applications of surface plasmon resonance biosensors: analysis of protein arrays. Exp Mol Med 37, 1-10.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Daniel Ricklin
    • 1
  • John D. Lambris
    • 2
  1. 1.Department of Pathology and Laboratory MedicineUniversity of PennsylvaniaPhiladelphia
  2. 2.Department of Pathology and Laboratory MedicineUniversity of PennsylvaniaPennsylvania

Personalised recommendations